Evidence map›Paper›PMID 38021248›Full record

ArticleFrontiers in human neuroscience2023

A targeted strategic peer support intervention to increase adherence to video teletherapy exposure and response prevention treatment for obsessive-compulsive disorder: a retrospective observational analysis.

Christopher E Murphy, Andreas Rhode, Jeremy Kreyling, Scott Appel, Jonathan Heintz, Kerry Osborn, Kyle Lucas, Reza Mohideen, Larry Trusky, Stephen Smith and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in human neuroscience, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Treatment of Obsessive-Compulsive Disorder via Mental Health Technology.The Psychiatric clinics of North America · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 3 countries.

Christopher E MurphyMichener Institute of Education at the University Health Network, Toronto, ON, Canada.
Andreas RhodeNOCD Inc., Chicago, IL, United States.
Jeremy KreylingNOCD Inc., Chicago, IL, United States.
Scott AppelBiostatistics Analysis Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.
Jonathan HeintzBiostatistics Analysis Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.
Kerry OsbornNOCD Inc., Chicago, IL, United States.
Kyle LucasNOCD Inc., Chicago, IL, United States.
Reza MohideenNOCD Inc., Chicago, IL, United States.
Larry TruskyNOCD Inc., Chicago, IL, United States.
Stephen SmithNOCD Inc., Chicago, IL, United States.
Jamie D FeusnerNOCD Inc., Chicago, IL, United States.
University of Pennsylvania · USUniversity Health Network · CAUniversity of Toronto · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Exposure and response prevention (ERP) therapy, a form of cognitive-behavioral therapy, is a first-line, evidence-based treatment for obsessive-compulsive disorder (OCD) for adults and children. It is effective for the majority of those who engage in it, but treatment adherence can be challenging for some due to the stress involved in the treatment as well as different life circumstances that arise. To help improve treatment adherence, NOCD, a provider of video teletherapy ERP, identifies those at risk of non-adherence using a prediction algorithm trained on a data set of

Indexed as

adherencecognitive-behavioral therapyexposure and response preventionmachine learningOCDpeer supporttelehealth

Identifiers

PMID38021248
PMCPMC10643166
OpenAlexW4388023404

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.